PolyPeptide Shares Surge Amid Takeover Interest From EQT, KKR

PolyPeptide Group AG shares hit the highest level in more than three years, after people with knowledge of the matter said the Swiss contract drugmaker is attracting private equity takeover interest.

Original Source

Read the full article at Financialpost →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.